Smart Syringe Global Market Report 2024

The smart syringe market has grown rapidly in recent years. It will grow from $10.32 billion in 2023 to $11.43 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The expansion observed in the historical period can be attributed to several factors, including the imperative for medication safety, the prevalence of blood-borne diseases, adherence to regulatory requirements, global initiatives for immunization, and a heightened awareness of healthcare practices.

The smart syringe market is expected to see rapid growth in the next few years. It will grow to $17.23 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%.The anticipated growth in the forecast period is driven by global vaccination initiatives, the imperative to prevent medication errors, an increase in chronic diseases, the expansion of home healthcare services, and government-led healthcare initiatives. Noteworthy trends expected during the forecast period encompass collaborations and partnerships, a strong emphasis on regulatory compliance, widespread adoption in vaccination programs, a focus on sustainable materials, and an expansion into emerging markets.

The anticipated increase in needlestick injuries is poised to drive the growth of the smart syringes market. Needlestick injuries, characterized by accidental punctures of healthcare workers' skin with needles or sharp medical devices, can be mitigated through the use of smart syringes. Equipped with advanced safety features such as retractable needles, smart syringes automatically retract to prevent accidental needlestick injuries and the subsequent transmission of diseases such as HIV and Hepatitis B. A survey conducted in Saudi Arabia in May 2022 by Frontiers Media revealed that among 361 healthcare workers, 36% of physicians and 34.8% of nurses experienced needlestick injuries in 2021. Notably, 53.8% of these injuries were not reported to the authorities, underscoring the importance of smart syringes in addressing this concern.

The increasing prevalence of blood-borne diseases is expected to contribute significantly to the growth of the smart syringes market. Blood-borne diseases, transmitted through contact with infected blood or bodily fluids, pose a substantial public health challenge. Smart syringes, designed with mechanisms that automatically disable the plunger after a single use, serve as a crucial tool in preventing the spread of blood-borne diseases and protecting users from accidental needlestick injuries. In August 2023, the Centers for Disease Control and Prevention reported 14,229 cases of chronic hepatitis B in the US, with a rate of 5.9 cases per 100,000 people in 2021. Notably, 73% of acute hepatitis B patients were aged 30-59 years. This data highlights the significance of smart syringes in addressing the growing prevalence of blood-borne diseases and driving market growth.

The smart syringes market is witnessing a prominent trend driven by product innovations, with major companies actively introducing groundbreaking solutions to enhance their market positioning. A notable example is the introduction of the Gx InnoSafe safety syringe by Gerresheimer, a leading Germany-based manufacturer specializing in drug delivery systems and packaging products. Launched in October 2021, the Gx InnoSafe safety syringe represents a first-in-class product featuring an integrated passive safety system. Its distinctive feature lies in the needle being securely fixed in an integrated safety sleeve after use, effectively preventing accidental needlestick injuries. Additionally, the product stands out for its user-friendly design, eliminating the need for additional assembly during the syringe-filling process.

Companies at the forefront of the smart syringes market are actively investing in technological advancements, incorporating innovations such as Near Field Communication (NFC) technology to gain a competitive advantage. NFC is a short-range wireless communication technology facilitating contactless data exchange between devices. NP Plastibell, a France-based medical device manufacturer, exemplifies this trend with the launch of its Pre-filled Smart Syringe in May 2022. This smart syringe incorporates an embedded NFC chip that transmits essential information about the medication to both practitioners and patients. The NFC chip stores crucial details, including drug name, dosage, expiration date, and lot number, allowing easy access through smartphones or other NFC-enabled devices.

In July 2022, Sharps Technology, a prominent US-based medical device manufacturer, acquired Safeguard Medical's smart syringes manufacturing facility for $2.5 million. This acquisition is aimed at expanding Sharps' manufacturing capabilities to meet the rising demand for smart syringes. Safeguard Medical, a US-based manufacturer specializing in smart syringes and emergency medical technologies, contributes to Sharps Technology's growth strategy in this dynamic market landscape.

Major companies operating in the smart syringe market report are Becton Dickinson and Company, Gerresheimer AG, Baxter International Inc., Terumo Corporation, Braun Melsungen AG, Cardinal Health Inc., Smiths Medical Inc., Parker-Hannifin Corporation, Retractable Technologies Inc., AdvaCare Pharma, Numedico Technologies Pty Ltd., Merit Medical Systems Inc., Nipro Corporation, Revolutions Medical Corporation, Sharps Technology, Unilife Corporation, West Pharmaceutical Services Inc., Schott AG, Vetter Pharma International GmbH, Catalent Inc., Agilent Technologies Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Trajan LEAP PAL Parts + Consumables, Clayens-np, Haselmeier GmbH, Owen Mumford Ltd., Ypsomed Holding AG, Weigao Group, Jiangsu Huida Medical Instruments Co. Ltd., Shandong Weigao Group Medical Polymer Co. Ltd., Zibo Minkang Pharmaceutical Packing Co. Ltd.

North America was the largest region in the global smart syringes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart syringe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the smart syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of smart syringes include auto-disable syringes, active safety syringes, and passive safety syringes. Auto-disable syringes are specifically engineered to prevent reuse after a single injection. Widely employed in immunization campaigns, these syringes automatically lock after a single use, ensuring the secure and contamination-free delivery of doses. This versatile solution caters to various segments, including pediatrics and adults, and finds applications in drug delivery, vaccination, and blood specimen collection. Auto-disable syringes are utilized across diverse industries, including hospitals, health maintenance organizations (HMOs), diabetic patient care, family practices (physicians), psychiatry, and more.

The smart syringes market research report provides smart syringes market statistics, including smart syringes industry global market size, regional shares, competitors with a smart syringes market share, detailed smart syringes market segments, market trends, and opportunities, and any further data you may need to thrive in the smart syringes industry. These smart syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart syringes market consists of sales of exchangeable needle syringes and fixed needle syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.